CABG or Stents: How Does the Heart Team Choose for Coronary Artery Disease?

The angiogram is still up on the screen when the cardiologist says the sentence nobody rehearses for: “There are three narrowings, and we’d like to talk about the best way to treat them.” One option sounds small, a tube through the wrist and home tomorrow. The other sounds enormous, an open chest, a week in hospital, a scar. It is natural to hear those two descriptions and assume the smaller one must be better.

Yet the cabg vs stents decision is not a contest between a gentle option and a brutal one. It is a question about plumbing, biology and time: which approach is most likely to keep blood flowing to this particular heart muscle for the longest, with the least risk to this particular person. Cardiologists and surgeons now sit in the same room to answer it, and they are reading things on that screen that most patients have never been taught to see.

This explainer walks through what they look for, why the answer differs from one person to the next, and what to ask when the conversation turns to you.

Why is the cabg vs stents decision made by a team, not one doctor?

For decades the person who did the angiogram often decided what happened next. If a cardiologist threaded the catheter, stents tended to follow; if a surgeon saw the patient first, an operation was more likely. Neither doctor was acting in bad faith. People simply recommend what they know best, and the two disciplines rarely compared notes.

International guidelines from cardiology and surgical societies changed that expectation. For anyone with disease in several arteries, or a narrowing in the left main artery that feeds most of the heart, the recommended standard is a heart team discussion: an interventional cardiologist (a cardiologist who places stents through catheters), a cardiac surgeon and usually the patient’s general cardiologist review the same images together before anyone proposes a plan. Anesthesiologists, imaging specialists and heart failure physicians join when the case calls for it.

The point is not politeness. The two treatments carry different early risks and different long-term behavior, and the balance shifts with the anatomy. A surgeon spots a segment too diffusely diseased for a stent to hold open; a cardiologist notices that a patient’s lungs or prior chest radiation would make an operation riskier than the images alone suggest. Put together, those observations produce a recommendation that neither specialist would have reached alone.

Patients sometimes worry that being “discussed at a meeting” means being reduced to a case number. In practice the opposite is true. The team is asked to consider the whole person: kidney function, frailty, how far someone can walk, whether they live alone, and what they say matters most to them. The meeting produces a recommendation, not an order. The final choice belongs to the patient, informed by a treating team that has looked at the problem from both sides.

What actually happens during coronary artery bypass grafting?

Coronary artery bypass grafting, shortened to CABG and pronounced “cabbage,” is an operation that creates a new route for blood around a blocked segment of a coronary artery, using a blood vessel borrowed from elsewhere in the body. The narrowing itself is left in place; the graft simply delivers blood past it, the way a bypass road skirts a congested town center.

The vessels most often used are the internal thoracic (mammary) arteries that run inside the chest wall, the radial artery from the forearm, and the great saphenous vein from the leg. Surgeons prefer arterial grafts where they can, particularly the left internal thoracic artery to the front wall of the heart, because arteries tend to stay open longer than veins once repurposed. Most people have between one and four grafts placed in a single operation, depending on how many arteries need help.

The standard approach opens the breastbone along its length. In the traditional technique the heart is stopped and a heart-lung machine takes over circulation while the surgeon sews the grafts, each connection roughly the width of a pencil lead. In an “off-pump” variation the heart keeps beating and a stabilizer holds a small patch still. Some centers offer smaller incisions or robotic assistance for selected patients, though the principle is identical.

According to the NHS, the operation usually takes 3 to 6 hours, and patients spend the first night or two in an intensive care unit before moving to a regular cardiac ward. The chest is closed with wires that stay permanently and do not usually set off airport detectors. Recovery is a matter of weeks rather than days, which is the honest price of a treatment designed to last for years.

What actually happens when a coronary stent is placed?

A stent is a tiny mesh tube, most often made of a cobalt or platinum alloy, that props a narrowed artery open from the inside. Placing one is called percutaneous coronary intervention (PCI), or coronary angioplasty with stenting; “percutaneous” simply means through the skin, with no surgical incision.

The procedure begins where the diagnostic angiogram did. A local anesthetic numbs the wrist or groin, a thin sheath enters the artery, and a catheter travels up to the heart while the patient stays awake. Contrast dye outlines the blockage on X-ray. A hair-thin wire crosses the narrowing, a balloon is inflated for a few seconds to compress the plaque against the wall, and the stent, folded around a second balloon, is expanded to hold the channel open. Once released, the mesh stays in place for life and the artery wall grows over it within months.

Nearly all stents used today are drug-eluting: they are coated with a medicine that slowly releases into the vessel wall to discourage scar tissue from narrowing the channel again. That coating is also why a period of blood-thinning tablets follows, since the metal can attract clot until the lining heals. The exact medicines and duration are decided by the treating cardiologist based on bleeding risk and the reason for the stent.

The NHS notes that angioplasty usually takes between 30 minutes and 2 hours, and many patients go home the same day or the following morning. Modern additions include intravascular imaging, where a miniature ultrasound or light probe measures the artery from the inside, and pressure wires that test whether a narrowing is actually restricting flow. Both help the team decide whether a lesion needs a stent at all.

Bypass surgery vs stent: what the angiogram pictures reveal

The single biggest influence on the bypass surgery vs stent question is not age or fitness but geography: which arteries are narrowed, how many, and what the narrowings look like.

Three main vessels supply the heart. The left anterior descending artery runs down the front and feeds the largest share of muscle, the circumflex wraps around the left side, and the right coronary artery supplies the back and bottom. Feeding the first two is a short trunk called the left main stem. Disease in the left main or in the top section of the left anterior descending is treated with particular seriousness, because a problem there threatens a large territory at once.

Beyond location, the team reads the character of each lesion. A short, focal narrowing in a wide, straight segment is a stent’s natural habitat. Long stretches of diffuse disease, heavy calcium that resists balloon expansion, narrowings at branch points where one stent can jail a side vessel, and complete blockages that have been present for months all make PCI technically harder and less durable. Bypass has an advantage here because the graft is attached downstream of the entire diseased zone, protecting the muscle even if plaque grows in the segment above.

The team also asks whether the arteries beyond the blockages are healthy enough to receive a graft. A surgeon cannot sew onto a vessel that is itself diffusely diseased or too small, which occasionally tips a case back toward stents even when the pattern otherwise suggests surgery.

Finally, imaging tests such as an echocardiogram (an ultrasound of the heart) or a stress scan show how much muscle is still alive and how well the heart pumps. Muscle that has already scarred gains little from restored blood flow, whatever the method, and that finding can change the whole conversation.

SYNTAX score explained: putting a number on complexity

Because “complex anatomy” is a vague phrase, cardiologists developed a way to score it. The SYNTAX score, named after the trial that introduced it, assigns points to every significant narrowing on an angiogram based on where it sits, how long it is, whether it involves a branch point, whether it is completely blocked, and how much calcium or clot is present. The points are summed into a single number that broadly sorts patients into low, intermediate and high complexity.

The logic is straightforward. In the lower band, stents and surgery have tended to perform similarly on the outcomes that matter most, so the lower upfront risk of PCI often wins. As the score climbs, the durability advantage of bypass grows, and guidelines increasingly favor surgery for patients who are fit enough to have it. The score is a tool for the discussion rather than a verdict, and it is one reason the heart team looks at the raw images together rather than reading a summary.

A companion set of scores estimates the other side of the ledger: how risky an operation would be for this person. Surgical risk calculators combine age, kidney function, lung disease, diabetes, prior stroke, heart pump strength and other factors to estimate the chance of a serious complication. A high anatomic complexity score paired with a low surgical risk points one way; the same anatomy in a frail patient with poor lungs points another.

Newer versions blend the two into a single estimate of longer-term outcome, and some add frailty measures such as walking speed or grip strength. None of them capture everything. They do not know that a patient cares for a spouse with dementia, or would rather accept a second procedure in five years than a long recovery now. Those facts enter the room only if someone asks.

Why does diabetes tilt the cabg vs stents decision toward surgery?

Ask a heart team which single medical condition changes their recommendation most often and many will answer: diabetes. The reason is biological rather than statistical.

Persistently raised blood sugar damages the lining of blood vessels throughout the body. In the coronary arteries this tends to produce disease that is diffuse rather than focal, involves smaller vessels, progresses faster and affects several arteries at once. A stent treats the few centimeters it covers. If the plaque above and below it keeps growing, which is more likely in diabetes, new narrowings can appear beside the stent or elsewhere in the same vessel. A bypass graft sewn well downstream keeps working regardless of what happens in the native segment it bypasses.

Randomized trials comparing the two approaches in people with diabetes and multivessel disease have consistently found fewer late heart attacks and fewer repeat procedures after surgery, which is why major cardiology and surgical guidelines give bypass a stronger recommendation in that specific group. The trade-off is the early period: surgery carries a higher short-term risk of stroke and a longer recovery, and the benefit accrues over years rather than months.

Diabetes also brings practical wrinkles. Wound healing at the chest and leg incision sites can be slower, and blood sugar has to be managed closely around any procedure. Kidney function, often reduced in long-standing diabetes, matters for both options, since contrast dye during PCI and the heart-lung machine during surgery each place a load on the kidneys.

None of this makes stents wrong for a person with diabetes who has a single focal narrowing, or who is having a heart attack, or whose other illnesses make an operation unwise. It means that when the anatomy is extensive and the patient is a reasonable surgical candidate, the scales start tipped, and the team will say so.

Multivessel disease treatment: when two or three arteries are narrowed

Multivessel disease means significant narrowings in two or all three of the main coronary arteries. It is the situation in which the heart team discussion earns its keep, because either approach can technically treat it and the right choice depends on details.

The first question is how well the heart pumps. Ejection fraction, the percentage of blood the main pumping chamber pushes out with each beat, is measured on echocardiography. When it is reduced, meaning the muscle is already struggling, guidelines lean toward bypass in patients who can tolerate it, particularly when the muscle is stunned rather than scarred and stands to recover with restored flow. Surgery also allows a surgeon to repair a leaking heart valve in the same operation, something PCI cannot offer.

The second question is whether complete revascularization is achievable, meaning every significant narrowing is treated rather than only the worst one. Surgery achieves this more reliably in diffuse disease because grafts do not depend on the length or calcium of each lesion. Stenting can achieve it too, sometimes in two staged sessions weeks apart, when the lesions are focal and accessible.

A third path exists: the hybrid approach. A surgeon grafts the left anterior descending artery through a small incision, taking advantage of the exceptional longevity of the internal thoracic artery graft, and a cardiologist stents the remaining vessels. It suits a minority of patients and requires close coordination, but it shows that the two disciplines are no longer competing camps.

Timing matters as much as method. Someone admitted with an evolving heart attack usually has the culprit artery opened with a stent within minutes to hours, and the remaining narrowings discussed once the emergency has passed. Someone with stable symptoms has time to have tests repeated, medicines adjusted and the options weighed at leisure. The same three blockages can reasonably lead to different plans depending on the day they were found.

Who is usually offered stents, who is offered bypass, and who is asked to wait?

Patterns emerge once you have watched enough heart team meetings, even though every case is argued individually.

Stents are the usual first choice when a heart attack is under way, because speed saves muscle and surgery cannot be arranged in minutes. They also suit one or two focal narrowings in straight segments, disease that spares the left main and proximal left anterior descending, and patients whose other illnesses make an operation risky: severe lung disease, advanced frailty, prior chest radiation, a heavily calcified aorta or a very recent stroke. Someone who has already had bypass surgery and develops a new narrowing is often stented rather than reoperated, since a second chest opening carries more hazard.

Bypass is more often recommended for left main disease with complex anatomy, three-vessel disease with a high complexity score, diabetes combined with multivessel disease, a weakened pump that stands to recover, and situations where a valve also needs repair. It is favored when the anatomy is unlikely to be fully treatable with stents, or when a previous stent has repeatedly narrowed.

Then there is a third group that surprises people: those asked to wait. In stable angina (chest discomfort on exertion that settles with rest), opening arteries has not been shown to prevent heart attacks or extend life compared with well-managed medicines in patients without high-risk anatomy. For them, the heart team may recommend optimizing medicines first and reserving any procedure for symptoms that persist. Waiting can also be advised after a recent stroke, during an active infection, or when kidney function needs to recover before more contrast dye is given.

Being asked to wait is not the same as being turned down. It is a judgment that, for now, the risks of intervening outweigh the gains, and that judgment is revisited whenever symptoms or test results change.

CABG and stents side by side: a plain comparison

The table below summarizes how the two approaches differ in the ways patients most often ask about. Figures are typical ranges reported by the NHS and the Mayo Clinic for uncomplicated cases; an individual course can be shorter or longer, and the treating team will give a personal estimate.

Question	Stents (PCI)	Bypass surgery (CABG)
What is done	Mesh tube expanded inside the narrowing via a catheter	New vessel sewn to bypass the blocked segment
Anesthesia	Local numbing at the wrist or groin, patient awake	General anesthesia, breastbone opened
Procedure length	About 30 minutes to 2 hours (NHS)	About 3 to 6 hours (NHS)
Usual hospital stay	Same day or next day (NHS)	Around 7 days (NHS)
Return to most activities	Often within about a week (NHS)	Around 6–12 weeks, full recovery by roughly 12 weeks (NHS, Mayo Clinic)
Main early risks	Bleeding at access site, artery injury, contrast effect on kidneys, rare heart attack or stroke	Bleeding, infection, irregular rhythm, stroke, kidney strain, memory or mood changes in early weeks
Long-term behavior	Treats only the stented segment; disease elsewhere can progress	Protects territory downstream of the graft; vein grafts can narrow over years
Where it tends to be favored	Heart attack, focal one- or two-vessel disease, high surgical risk	Left main or three-vessel disease, diabetes with multivessel disease, weak pump, valve repair needed

Two things the table cannot show deserve emphasis. First, the risks are not equal in shape: PCI concentrates its risk in the hours around the procedure, while surgery spreads it across a longer recovery. Second, both leave the underlying disease in place. Whichever route is chosen, the arteries that were not treated keep aging, and the medicines and habits that slow that process matter just as much afterward as before.

What about medicines alone? Where optimal medical therapy fits

It would be easy to leave this section out, since the title asks about procedures. That would misrepresent how the heart team thinks. Medicines are not the fallback when procedures are refused; they are the foundation that every procedure sits on.

Coronary artery disease is a process, not a set of blockages. Cholesterol-rich plaque builds inside artery walls over decades, inflames, and sometimes ruptures, triggering a clot that causes a heart attack. A stent or graft addresses the narrowings visible today. Medicines address the process. Statins lower the cholesterol that feeds plaque and appear to stabilize its cap; antiplatelet medicines make blood less likely to clot on a rough surface; blood pressure medicines reduce the strain on artery walls; medicines that slow the heart or relax vessels ease angina by cutting the muscle’s oxygen demand. The prescribing clinician chooses among them based on the individual, and any change belongs in that conversation.

For stable angina without high-risk anatomy, large randomized trials have found that a strategy of medicines and lifestyle change, with procedures reserved for those whose symptoms persist, produces similar rates of heart attack and death to an early procedure. That finding shapes the heart team’s advice more than most patients realize: it is the reason “let’s optimize your medicines and reassess” is a legitimate recommendation, not a brush-off.

After either procedure, medical therapy continues. The NHS notes that following a stent, a combination of antiplatelet tablets is usually taken for a period of months up to about a year, with a single agent thereafter, the details set by the cardiologist. After bypass, statins and antiplatelets are similarly standard. Stopping them without medical advice is one of the most avoidable causes of harm after either treatment, which is why the discharge conversation about medicines deserves as much attention as the one about the procedure itself.

What do the first days and weeks look like after each procedure?

Recovery is where the two options feel most different, and it is worth picturing honestly before choosing.

After a stent, most people sit up within hours. If the wrist was used, a compression band stays on for a few hours and the arm is kept relatively still; if the groin was used, lying flat for several hours prevents bleeding. The NHS advises that patients can usually go home the same day or the next, should avoid driving for about a week, and can often return to work within a week, though physically demanding jobs may need longer. Bruising at the access site is common and fades over a couple of weeks. The day-to-day sensation is often that little happened, which is both the appeal and the trap of PCI: the disease has been treated, not the sense of urgency about the habits that drove it.

After bypass, the first two days pass in intensive care with monitoring lines and a breathing tube that is usually removed within hours of waking. Walking begins in the corridor within a day or two, deliberately, because movement clears the lungs and prevents clots. The NHS describes a typical hospital stay of around 7 days. At home, the breastbone needs about 6 weeks to knit, so heavy lifting, pushing up from chairs with the arms and driving are restricted during that period. Fatigue, poor sleep, low mood and a wandering appetite are common in the early weeks and usually lift. Mayo Clinic describes full recovery as taking about 6 to 12 weeks for most people, with the NHS giving a similar 12-week horizon.

Cardiac rehabilitation, a supervised program of graded exercise, education and support, is recommended after both procedures. Uptake after stents is lower, partly because people feel well. The evidence for rehab is strong in both groups, and asking for a referral is one of the highest-value questions a patient can raise before leaving hospital.

What people often get wrong about bypass and stents

Some beliefs about these treatments are so common that heart teams hear them weekly. Each contains a grain of truth and a larger misunderstanding.

“A stent fixes the heart disease.” It relieves one narrowing. The plaque process continues in every untreated centimeter of artery, which is why medicines and lifestyle change remain the main long-term therapy after any procedure.

“Surgery is only for people too sick for stents.” Often the reverse is true. Bypass is frequently recommended to relatively fit patients with extensive disease precisely because they are well enough to gain its long-term advantages. The frailest patients are more often steered toward stents or medicines.

“Opening the artery will prevent my heart attack.” In an ongoing heart attack, yes, urgently. In stable angina without high-risk anatomy, trials have not shown that stents prevent future heart attacks compared with good medical therapy; they relieve symptoms. Understanding that distinction protects people from disappointment and from unrealistic expectations.

“Bypass grafts last forever.” Arterial grafts, especially the internal thoracic artery, have an excellent record over decades. Vein grafts are more prone to narrowing over the years, and the native arteries keep aging. Many bypass patients later need a stent in a graft or elsewhere, and that is expected rather than a failure.

“The wrist procedure is trivial.” It is remarkably safe, but it involves an artery, contrast dye, radiation and a permanent implant. Rare complications include bleeding, kidney injury and stroke, and the team weighs them just as they weigh surgical risk.

“If they recommend waiting, they’ve given up on me.” A recommendation to optimize medicines first reflects evidence, not neglect. The plan is reviewed whenever symptoms change.

“More stents means better treatment.” Each stent is a site where clot or scar can form. The team aims to treat what restricts flow and leave alone what does not, guided increasingly by pressure wires and imaging rather than the picture alone.

How the heart team approach works when the doors close

Patients rarely see the meeting where their images are discussed, so it helps to know what happens there.

Most centers hold a scheduled multidisciplinary conference, often weekly, with urgent cases discussed on the day. The angiogram is projected and reviewed frame by frame. Someone presents the clinical story: symptoms, how far the person walks, previous procedures, kidney and lung function, diabetes control, medicines already tried. The echocardiogram is shown. Complexity and surgical risk scores are read out, then argued with, because experienced clinicians know the scores miss things.

The interventional cardiologist describes what stenting would involve and where it would struggle: a calcified segment that might need a specialized device to crack, a branch point that risks a side vessel. The surgeon describes the operation, including which grafts are available and whether the target vessels are large enough to receive them. If a valve leaks or the aorta is heavily diseased, that changes the surgical plan and sometimes rules it out. Anesthesiology weighs in on frailty and lung reserve.

Then comes the part patients most want to know exists: someone asks what the person wants. A team member who has spoken to the patient relays their priorities, whether that is avoiding a long recovery, minimizing the chance of a repeat procedure, staying independent at home or getting back to a physically demanding job. Guidelines explicitly place patient preference alongside anatomy in the decision.

The meeting closes with a documented recommendation, sometimes with two acceptable options ranked, which is then taken back to the patient in a consultation where questions are expected. Seeking a second opinion is reasonable and routine; a well-functioning heart team has already, in effect, provided several. What matters is that the person in the chair understands why the recommendation landed where it did, and feels free to choose differently.

Questions to ask your care team before deciding

A good consultation leaves you able to explain your own case to a friend. These questions tend to draw out the reasoning behind a recommendation rather than just the recommendation itself.

• Which arteries are narrowed, how severely, and does any narrowing involve the left main or the top of the left anterior descending artery?
• Was my case discussed by a heart team including a surgeon, and did they agree? If two options were considered acceptable, what tipped the balance?
• How well is my heart pumping, and is there muscle that is expected to recover if blood flow is restored?
• Do I have diabetes or kidney disease that changes the recommendation, and how?
• Could my symptoms reasonably be managed with medicines first, and what would we watch for to decide the timing of any procedure?
• If stents are proposed, can every significant narrowing be treated, or will some be left? Would intravascular imaging or a pressure wire be used to guide the decision?
• If surgery is proposed, which grafts would be used, is an off-pump or smaller-incision approach an option for me, and would anything else be repaired at the same time?
• What are the most likely complications for someone with my profile, and how would each be handled?
• What does the first month at home look like, what will I be unable to do, and who will I call with questions?
• Which medicines will I take afterward, for how long is each likely to continue, and what should I never stop without speaking to you?
• Will I be referred to cardiac rehabilitation, and when does it start?
• If I chose the other option, what would I be trading?

Bring someone to listen, ask for the answers in writing or in the patient record, and do not hesitate to say you need time. Outside a heart attack, a few days spent understanding the choice is time well spent.

When to call your doctor

Coronary artery disease can change quickly, and both procedures have a small number of warning signs that should never wait for a routine appointment.

Call emergency services immediately if you develop chest pain, pressure or tightness that lasts more than a few minutes or comes and goes, particularly if it spreads to the arm, jaw, neck or back, or arrives with sweating, breathlessness, nausea or lightheadedness. The same applies to sudden weakness or numbness on one side, facial drooping, slurred speech or sudden confusion, which can signal a stroke. Fainting, a racing or wildly irregular heartbeat with dizziness, or breathlessness so severe you cannot speak in full sentences also warrant an emergency call. Do not drive yourself.

After a stent, contact your cardiology team or urgent care the same day for swelling, expanding bruising, a pulsating lump or bleeding at the wrist or groin site that does not stop with firm pressure, a hand or leg that turns cold, pale or numb, fever, or a return of the angina you had before the procedure. Also call before stopping any antiplatelet medicine for any reason, including a dental or surgical procedure elsewhere.

After bypass, seek same-day advice for a chest or leg wound that becomes red, hot, swollen, leaks fluid or opens; a clicking or shifting sensation in the breastbone; fever or chills; a swollen, painful calf; breathlessness that is worsening rather than easing; weight gain of more than a couple of kilograms over a few days with ankle swelling; or a heart rhythm that feels newly irregular. Low mood is common after surgery, and persistent hopelessness or thoughts of self-harm deserve a prompt call too.

When in doubt, the rule most cardiac teams give at discharge holds: call. A conversation that turns out to be unnecessary costs little; a warning sign ignored can cost a great deal.

Frequently asked questions

Is bypass surgery vs stent a decision I get to make, or does the doctor decide?

You make the final decision, informed by the heart team’s recommendation. Guidelines from cardiology and surgical societies explicitly include patient preference alongside anatomy and risk when weighing bypass surgery against stents. The team’s job is to explain why one approach is likely to serve you better and what you would trade by choosing the other. Outside an emergency, you are entitled to time, written information and a second opinion before you commit.

What is the SYNTAX score and should I ask for mine?

The SYNTAX score is a number that grades how complex your coronary narrowings are, based on their location, length, calcium, branch involvement and complete blockages. Higher scores generally favor bypass surgery; lower scores mean stents and surgery tend to perform similarly. It is reasonable to ask whether it was calculated and what band it fell into, while understanding that it is one input among many, alongside surgical risk, pump function and your own priorities.

Why does the heart team approach take longer than just getting a stent?

Because the two treatments behave differently over years, and the right choice depends on details a single specialist can miss. A heart team review typically adds days, not weeks, for stable patients and is bypassed entirely during a heart attack, when the culprit artery is opened urgently. The extra time buys a plan checked from both the catheter and the operating table perspectives, which guidelines consider the standard of care for complex or multivessel disease.

Can I have stents now and bypass later if the stents fail?

Often yes, though the sequence has consequences. Stents that later narrow can sometimes be re-treated with another stent, and bypass remains possible in many cases. Extensive prior stenting can, however, complicate where a surgeon can attach grafts, and reoperation risks rise if a chest has already been opened. This is one reason the team tries to choose the durable option first when anatomy allows, rather than treating stents as a risk-free trial run.

How long after multivessel disease treatment before I can exercise normally?

It depends on the procedure. After stents, the NHS suggests most people resume ordinary activities within about a week, building exercise gradually. After bypass, the breastbone needs about 6 weeks to knit and full recovery takes roughly 12 weeks, so lifting and upper-body strain are restricted during that time while walking is encouraged from the first days. A cardiac rehabilitation program provides a supervised, individualized path back to activity after either treatment.

Does having a stent mean I will be on blood thinners for life?

Not usually on two. After a drug-eluting stent, a combination of two antiplatelet medicines is typically taken for a period of months up to about a year according to the NHS, after which a single antiplatelet agent commonly continues long term to protect the arteries generally. The exact medicines and duration depend on why the stent was placed and your bleeding risk, and only the prescribing cardiologist should adjust them. Never stop them for a dental or other procedure without checking first.

Is bypass surgery safer than stents for someone over 80?

Age alone does not decide it. Older patients who are active and have few other illnesses can do well with surgery when their anatomy favors it, while frail patients with lung, kidney or cognitive problems are often better served by stents or medicines. Heart teams assess frailty, walking ability and independence rather than the birth year, and a smaller or staged procedure is sometimes chosen to protect quality of life over theoretical long-term gain.

Will a stent or bypass stop me having a heart attack in future?

Neither treatment removes the underlying disease, so neither can promise that. During an ongoing heart attack, urgent stenting limits damage. In stable disease, bypass appears to reduce later heart attacks in some higher-risk groups, notably diabetes with multivessel disease, while stents mainly relieve symptoms. Long-term protection comes largely from medicines, not smoking, blood pressure and cholesterol control, activity and cardiac rehabilitation, whichever procedure you have.

What is a hybrid procedure and who is it for?

A hybrid approach combines a surgical graft to the front artery, often through a small incision, with stents to the remaining vessels, either in one session or staged over days. It aims to pair the long-lasting internal thoracic artery graft with the lighter recovery of stents. It suits a minority of patients with a specific pattern of disease and requires close coordination between surgeon and cardiologist, so availability varies and the heart team will say whether it fits your anatomy.

What if the heart team recommends medicines first and I still have chest pain?

Tell them, because persistent symptoms change the calculation. A trial of medicines is recommended for stable angina without high-risk anatomy because procedures have not been shown to prevent heart attacks in that setting, but they do relieve symptoms that medicines fail to control. If angina limits your life after a fair trial, the team can revisit stents or surgery. Any new pattern of pain, especially at rest or lasting more than a few minutes, needs urgent assessment.

References

• NHS: Coronary artery bypass graft (CABG)
• NHS: Coronary angioplasty and stent insertion
• Cleveland Clinic: Coronary artery bypass surgery

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.